Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Partner Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Partner Therapeutics

Partner Therapeutics

Public

Partner Therapeutics, Inc.: A Massachusetts-based biopharmaceutical company innovating cancer treatments.

HQ
Lexington, MA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Partner Therapeutics, Inc., founded in Massachusetts, is a biopharmaceutical company dedicated to developing and commercializing innovative cancer treatments. Their core mission is to enhance the effectiveness of existing therapies and bring new solutions to market, particularly focusing on oncology. The company's flagship product, LEUKINE® (Sargramostim), is used to stimulate the immune system in cancer patients. Partner Therapeutics aims to address unmet medical needs and improve patient outcomes through rigorous scientific research and strategic partnerships.

Notable figures affiliated with Partner Therapeutics include experienced leaders in biopharmaceuticals and oncology. The company has garnered support from key investors who believe in its mission to revolutionize cancer treatment. Among its significant achievements is the successful commercialization of LEUKINE®, which has shown promise in various clinical trials, including applications related to COVID-19. Overall, Partner Therapeutics has made a substantial impact by advancing therapeutic options and improving the quality of life for cancer patients.

Partner Therapeutics - Similar Companies

PanTher Therapeutics logo

PanTher Therapeutics

panthertx.com

Parthenon Therapeutics logo

Parthenon Therapeutics

parthenontx.com

Advanced Cancer Therapeutics logo

Advanced Cancer Therapeutics

Tango Therapeutics logo

Tango Therapeutics

tangotx.com

Elstar Therapeutics logo

Elstar Therapeutics

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

G1 Therapeutics logo

G1 Therapeutics

g1therapeutics.com

Pheast Therapeutics logo

Pheast Therapeutics

pheast.com

Starton Therapeutics logo

Starton Therapeutics

PIC Therapeutics logo

PIC Therapeutics

Blueprint Medicines logo

Blueprint Medicines

PineTree Therapeutics logo

PineTree Therapeutics

pinetreetx.com

Dual Therapeutics logo

Dual Therapeutics

Checkpoint Therapeutics logo

Checkpoint Therapeutics

checkpointtx.com

Bolt Biotherapeutics logo

Bolt Biotherapeutics

boltbio.com

Partner Therapeutics - Quick Facts

Who are Partner Therapeutics' competitors?

Companies similar to Partner Therapeutics include PanTher Therapeutics, Parthenon Therapeutics, Advanced Cancer Therapeutics and Tango Therapeutics.

When was Partner Therapeutics founded?

Partner Therapeutics was founded in 2017.

Where is Partner Therapeutics' headquarters located?

Partner Therapeutics' headquarters is located in Lexington, MA, US.

When was Partner Therapeutics' last funding round?

Partner Therapeutics' most recent funding round was for $60M (USD) in February 2018.

How much has Partner Therapeutics raised to-date?

As of Feb 1, 2018, Partner Therapeutics has raised a total of $60M (USD).

How many employees does Partner Therapeutics have?

Partner Therapeutics has 227 employees as of Feb 5, 2024.

Partner Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Cancer Treatments
Tags
  • Healthtech
  • Pharmaceutical
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified